Name
Tam Exemestane
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for Tam Exemestane
Name
Alternate Names
Alpha-Tamoxifen
Apo-Tamox
Dom-Tamoxifen
Gen-Tamoxifen
ICI-46474
Nolvadex
Nolvadex-D
Novo-Tamoxifen
PMS-Tamoxifen
Tamofen
Tamone
Tamoplex
Tamoxifen
Tamoxifen Citrate
Soltamox
Abbreviations
TAM
TMX
Category
Hormones and hormonal mechanisms
Subcategory
Nonsteroidal antiestrogen
NSC Number
180973
Primary Site
Breast
Histology
None
Remarks
A nonsteroidal antiestrogenic agent with combined partial-estrogen-agonist activity. FDA approved uses on breast cancer and risk reduction for women with high risk of developing breast cancer.
Literature shows that Tamoxifen is being prescribed for recurrent/relapsed ovarian cancer.
Literature shows that Tamoxifen is being prescribed for recurrent/relapsed ovarian cancer.
Coding
This drug should be coded
Name
Alternate Names
Aromasin
FEC 24304
FEC-24304
FEC24304
Nikidess
PNU 155971
PNU-155971
PNU155971
Abbreviations
None
Category
Hormones and hormonal mechanisms
Subcategory
Aromatase inhibitor
NSC Number
713563
Primary Site
Breast
other cancer
Histology
None
Remarks
FDA approved postmenopausal breast cancer; Phase II/III for other sites Steroidal aromatase inhibitor. Pharmacia, Pfizer. For adjuvant treatment of postmenopausal women with ER positive breast cancer who have completed 2-3 years of tamoxifen for completion of a total of 5 consecutive years of adjuvant hormonal therapy.
Coding
This drug should be coded